Instem plc Notice of Results (3621T)
March 20 2019 - 3:02AM
UK Regulatory
TIDMINS
RNS Number : 3621T
Instem plc
20 March 2019
20 March 2019
Instem plc
("Instem" or the "Company")
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the
global life sciences market, will announce full year results for
the year ended 31 December 2018 on Monday 1 April 2019.
Analyst Presentation
Management will be hosting a presentation on the day of the
results at 10.30am at the offices of Walbrook PR, 4 Lombard Street,
London, EC3V 9HD. Analysts wishing to attend the presentation
should register their interest by emailing instem@walbrookpr.com or
by telephoning 020 7933 8780.
Investor Presentation
The Company will also be hosting a presentation for investors in
London on Tuesday 2 April 2019. Phil Reason, CEO of the Company
will present financial and operational results for the year ended
31 December 2018, as well as an overview of the Company and its
plans for the future.
The event is open to all investors and will be held from 16.30
for a 16.45 start at a venue in the City. To register for the
event, please email instem@walbrookpr.com or call the Walbrook PR
team, below.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Richard Lindley
Rachel Hayes
Walbrook Financial PR +44 (0) 20 7933 8780
Paul Cornelius instem@walbrookpr.com
Nick Rome
Sam Allen
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by customers worldwide and enable
our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United
States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please
visit instem.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORFMGMFNLVGLZM
(END) Dow Jones Newswires
March 20, 2019 03:02 ET (07:02 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Instem (LSE:INS)
Historical Stock Chart
From Aug 2023 to Aug 2024